Tia
A hybrid women’s healthcare provider offering integrated primary care, gynecology, mental health, and wellness services.
Website: https://asktia.com
Cover Block
PUBLIC
| Attribute | Value |
|---|---|
| Name | Tia |
| Tagline | A hybrid women’s healthcare provider offering integrated primary care, gynecology, mental health, and wellness services. |
| Headquarters | San Francisco, California |
| Founded | 2017 |
| Stage | Series B |
| Business Model | Direct-to-Consumer (DTC) |
| Industry | Healthtech |
| Technology | Software (Non-AI) |
| Geography | North America |
| Growth Profile | Venture Scale |
| Founding Team | Co-Founders (2) |
| Funding Label | $100M+ (total disclosed ~$100,000,000) |
Links
PUBLIC
- Website: https://asktia.com
- LinkedIn: https://www.linkedin.com/company/asktia
Executive Summary
PUBLIC
Tia is a hybrid women's healthcare provider that has raised over $130 million to build a network of integrated clinics and virtual care, a bet that investors are backing to address the persistent fragmentation of women's health services [Fierce Healthcare, Oct 2022] [Fortune, May 2022]. The company was founded in 2017 by Carolyn Witte and Felicity Yost, initially as a chat-based app for birth control advice before expanding into physical clinics that combine primary care, gynecology, mental health, and wellness under one roof [The Helm] [TechCrunch, Mar 2019]. Its core differentiation is a care model that places the menstrual cycle at the center of a patient's health record, aiming to serve women who often fall between the silos of traditional OB-GYN and primary care [Oprah Daily].
The founding team brings a blend of consumer technology and venture capital experience. Witte, previously at Google, has been the public face of the company's mission, while Yost, a former investor at Human Ventures, is now confirmed as CEO following a leadership transition in late 2025 [Business Insider, Oct 2025] [Forbes, Nov 2018]. The business model operates on a dual revenue stream: a direct-to-consumer membership priced at $25 per month, and partnerships with health systems like UCSF Health to co-develop clinically integrated clinics [asktia.com] [AHA, Oct 2023]. Over the next 12-18 months, key developments to monitor include the execution of its clinic expansion and consolidation strategy, the scaling of its recently launched fertility and menopause services, and the financial impact of its recent workforce restructuring.
Data Accuracy: GREEN -- Key claims corroborated by multiple independent publications including Fierce Healthcare, Fortune, and Business Insider.
Taxonomy Snapshot
| Axis | Classification |
|---|---|
| Stage | Series B |
| Business Model | Direct-to-Consumer (DTC) |
| Industry / Vertical | Healthtech |
| Technology Type | Software (Non-AI) |
| Geography | North America |
| Growth Profile | Venture Scale |
| Founding Team | Co-Founders (2) |
| Funding | $100M+ (total disclosed ~$100,000,000) |
Company Overview
PUBLIC
Tia’s origin story is a classic startup narrative of personal frustration meeting market opportunity. Co-founders Carolyn Witte and Felicity Yost launched the company in 2017, reportedly from Witte’s dining room table in San Francisco, after Witte’s own negative experiences navigating the fragmented women’s healthcare system [Oprah Daily]. The initial product was a chat-based app focused on birth control and sexual health advice, a digital wedge that allowed them to build a direct consumer brand before expanding into physical care [The Helm] [TechCrunch, Mar 2019]. The company remains headquartered in San Francisco, California, and has grown through a series of strategic expansions, first adding virtual care and then launching its inaugural physical clinic in New York City in 2019 [TechCrunch, Mar 2019].
Key operational milestones trace a path from digital tool to hybrid care provider. The 2021 $100 million Series B round, led by Lone Pine Capital, provided the capital to accelerate clinic build-out and geographic expansion [MobiHealthNews]. By 2022, the company reported delivering 100,000 healthcare services and was on a path to serve 100,000 women nationwide by the end of 2023 [Fierce Healthcare, Oct 2022]. Its partnership strategy crystallized in 2022 with a collaboration to develop a network of clinically integrated clinics with UCSF Health in the Bay Area [Businesswire, May 2022]. More recent developments include a leadership transition, with co-founder Felicity Yost stepping into the CEO role and Carolyn Witte moving to chairwoman of the board, and a consolidation of its physical footprint, including the planned closure of its Santa Monica clinic in June 2025 [Fierce Healthcare] [asktia.com].
Data Accuracy: GREEN -- Founding details and key milestones corroborated by multiple independent sources including Oprah Daily, TechCrunch, and company announcements.
Product and Technology
MIXED
The core product is a hybrid care model that integrates virtual and in-person services under a single women's health brand. Tia's platform offers primary care, gynecology, mental health, and wellness services, including acupuncture, through a coordinated care team [Oprah Daily]. This integration of historically siloed specialties into one system and medical record is the central technical and operational challenge the company has addressed since its 2017 founding [TechCrunch, Mar 2019]. The service is accessed through a combination of a digital platform for virtual visits and scheduling, and a network of physical clinics in New York City, Los Angeles, San Francisco, and Phoenix/Scottsdale [asktia.com].
Tia's go-to-market is structured around two main customer pathways. The direct-to-consumer model offers a Tia membership for $25 per month or $240 per year, on top of insurance-billed visits, alongside a no-fee Tia Essential tier [asktia.com]. The company also pursues health-system partnerships, such as its collaboration with UCSF Health to develop a network of clinically integrated clinics in the Bay Area, which act as enterprise-level deployments [AHA, Oct 2023]. The product suite has expanded from its origins as a chat-based app for birth control advice to include fertility assessments, perimenopause and menopause management, and treatment for conditions like PCOS and endometriosis [asktia.com, Retrieved 2026].
A 2025 study cited by the company reports that many women aged 30-45 experience perimenopause-like symptoms, informing the launch of a Hormone & Vitality Assessment aimed at earlier intervention [Businesswire, Retrieved 2026]. The technology stack powering this hybrid experience is not detailed in public materials, but can be inferred from operational needs: it likely includes electronic health record (EHR) software, patient scheduling and communication tools, telehealth video infrastructure, and a patient-facing mobile application. The company has also integrated third-party services, such as referring patients to Talkspace for therapy and psychiatric services [MedCity News, Retrieved 2026].
Data Accuracy: GREEN -- Product claims are confirmed by the company website and multiple press reports.
Market Research
PUBLIC The women's health sector is experiencing a significant revaluation, moving from a historically underfunded niche to a mainstream investment category, driven by a confluence of demographic, economic, and technological forces.
Direct third-party market sizing for Tia's specific hybrid model is not publicly available. However, analogous market reports provide a relevant scope. The global women's health market was valued at approximately $41 billion in 2022 and is projected to reach $58 billion by 2030, growing at a compound annual rate of 4.5% [Grand View Research]. Within this, the U.S. market for women's digital health, which includes virtual care and platforms, was estimated at $1.3 billion in 2021 and is forecast to expand at a 19.3% CAGR through 2030 [Precedence Research]. These figures suggest a large and growing addressable market for integrated, tech-enabled services.
Demand is propelled by several tailwinds. A generational shift sees younger cohorts, accustomed to digital-first convenience, seeking more personalized and accessible care. The post-Dobbs legal landscape has heightened focus on reproductive health services and comprehensive primary care alternatives [AHA, Oct 2023]. Furthermore, increased employer and payer recognition of women's health as a driver of workforce productivity and overall healthcare cost management is creating new enterprise channels. The cited research positions Tia's model as addressing 'medical orphans',women whose needs fall between traditional OB-GYN and primary care silos, representing a substantial unmet demand [AHA, Oct 2023].
Adjacent and substitute markets include traditional fee-for-service OB-GYN and primary care practices, which Tia aims to displace through integration and experience. Telehealth giants and primary care disruptors (e.g., One Medical) represent broader competitive substitutes, though they typically lack the specialized, women-centric clinical focus. The company's partnership strategy with health systems like UCSF Health also positions it within the larger, multi-trillion-dollar U.S. healthcare delivery market, seeking to capture value through clinically integrated networks [Businesswire, May 2022].
Regulatory and macro forces are a double-edged sword. While favorable policy trends and employer mandates can accelerate adoption, operating a hybrid care model subjects Tia to complex state-by-state medical licensing, insurance reimbursement, and clinic accreditation rules. Macroeconomic pressures on consumer discretionary spending could impact the direct-to-consumer membership component, though health system partnerships may provide a counterbalancing, more resilient revenue stream.
Global Women's Health Market 2022 | 41 | $B
Global Women's Health Market 2030 (projected) | 58 | $B
U.S. Women's Digital Health Market 2021 | 1.3 | $B
U.S. Women's Digital Health Market 2030 (projected) | 6.8 | $B
The projected growth rates, particularly for the digital health segment, indicate a market in an expansion phase. This supports the fundamental premise behind Tia's venture-scale funding, though the company's ultimate market share will depend on its ability to execute its capital-intensive hybrid model against both specialized and generalist competitors.
Data Accuracy: YELLOW -- Market sizing relies on analogous third-party reports; direct TAM for Tia's specific model is unconfirmed.
Competitive Landscape
MIXED
Tia’s competitive position is defined by its attempt to build a comprehensive, integrated care model for women, a segment where traditional providers are fragmented and digital challengers are often point-solution specialists.
| Company | Positioning | Stage / Funding | Notable Differentiator | Source |
|---|---|---|---|---|
| Tia | Hybrid women's healthcare provider integrating primary care, gynecology, mental health, and wellness. | Series B ($132M total disclosed) | Physical clinic network combined with virtual care; menstrual cycle-centered, whole-person model. | [Fierce Healthcare, Oct 2022] |
| Maven Clinic | Virtual clinic for women's and family health, focused on fertility, pregnancy, and parenting. | Series E ($300M+) | Largest dedicated virtual care platform for family health; strong employer and health plan distribution. | [Crunchbase] |
| Ovia Health | Digital health platform providing personalized guidance for fertility, pregnancy, and parenting. | Acquired (by Labcorp) | Deep integration with employers and health plans as a preventative health benefit; clinical content library. | [Crunchbase] |
| Bia Care | Virtual menopause clinic offering specialist care, coaching, and community support. | Seed ($2.5M) | Highly specialized, clinician-led care model focused exclusively on the menopause transition. | [Crunchbase] |
The competitive map breaks into three primary segments. First, the incumbent healthcare system, where women typically navigate between separate primary care physicians, OB-GYNs, and mental health providers. This is Tia’s core target for disruption, as its integrated model aims to consolidate these historically siloed services [AHA, Oct 2023]. Second, digital-first challengers like Maven Clinic and Ovia Health, which have scaled rapidly by focusing on specific, high-demand life stages (fertility, pregnancy) and selling primarily through employers and health plans. Third, a growing cohort of specialized digital clinics, such as Bia Care for menopause, which compete on depth within a narrow condition rather than breadth.
Tia’s defensible edge today rests on its hybrid physical footprint and its early focus on the menstrual cycle as an organizing principle for care. The company’s nine clinics (as of late 2023) in key metropolitan markets create a tangible brand presence and a higher-touch service tier that pure-play virtual competitors cannot match [Oprah Daily]. Its partnership model with health systems, exemplified by the collaboration with UCSF Health, provides a capital-efficient path to clinic expansion and lends institutional credibility [Businesswire, May 2022]. This edge is durable if Tia can prove its clinical outcomes and unit economics at scale, but it is perishable if the capital intensity of physical locations outpaces membership growth or if larger health systems decide to build similar integrated offerings in-house.
The company’s most significant exposure lies in distribution and category breadth. Maven Clinic has established a formidable lead in the employer and health plan channel, a sales motion that Tia has pursued but not yet dominated [PUBLIC]. Furthermore, while Tia’s expansion into fertility and menopause care broadens its addressable market, it brings the company into direct competition with well-funded, focused players in each sub-segment who may move faster and with greater clinical specialization. Tia’s reliance on a direct-to-consumer membership fee on top of insurance could also be a friction point in a cost-conscious environment, compared to competitors fully bundled into employer benefits.
The most plausible 18-month scenario involves continued market segmentation. A winner in this environment would be a company that successfully locks in enterprise contracts for comprehensive women’s health. If Tia can use its UCSF partnership as a blueprint for more health system deals, it could secure a stable, capital-light growth channel. Conversely, a loser would be any player that fails to demonstrate clear clinical or economic ROI to payers. If Tia cannot translate its integrated care model into published outcomes data,such as the reduction in cardiovascular events or improved metabolic stability it aims to measure,it may struggle to justify its premium positioning against both incumbents and more focused digital providers [MedCity News].
Data Accuracy: YELLOW -- Competitor profiles and funding stages are drawn from Crunchbase and public coverage; Tia's own positioning and partnerships are well-sourced. Direct, detailed feature comparisons between Tia and its named competitors are less frequently published.
Opportunity
PUBLIC The opportunity for Tia is to become the definitive, integrated care platform for women's health, capturing a significant share of a market where patient demand for coordinated, whole-person care has consistently outpaced the fragmented supply.
The headline opportunity is to establish the first national, brand-defining medical home for women. This outcome is plausible because Tia is one of the few companies attempting to integrate historically siloed services,primary care, gynecology, mental health, and wellness,into a single, patient-owned medical record and experience [Oprah Daily]. The evidence that this model resonates is its reported traction: serving "tens of thousands of women" and delivering 100,000 services in 2022 [Oprah Daily], with patient retention reported at over 80% year-over-year [Fierce Healthcare, Retrieved 2026]. The strategic partnerships with established health systems like UCSF Health, aimed at co-developing clinically integrated networks, provide a credible path to scaling the model beyond a direct-to-consumer boutique service [Businesswire, May 2022].
Growth could follow several concrete paths, each with identifiable catalysts.
| Scenario | What happens | Catalyst | Why it's plausible |
|---|---|---|---|
| Enterprise Partnership Dominance | Tia's platform becomes the white-labeled or preferred women's health module for major health systems and payers. | A multi-system rollout of the UCSF Health partnership model, proving improved outcomes and cost savings. | The existing collaboration with UCSF Health is framed as a cornerstone for a broader Bay Area network [HCI Innovation Group, Retrieved 2026]. Tia already works with Catholic Health [AHA, Oct 2023]. |
| Vertical Integration in Fertility & Menopause | Tia captures the full patient journey for high-ACV conditions like infertility and perimenopause, from assessment through treatment. | Successful launch and adoption of its expanded fertility services and Hormone & Vitality Assessment [Fortune, May 2022][Businesswire, Retrieved 2026]. | The company has systematically built out its clinical offerings in these areas, which are core drivers of patient need and healthcare spending [asktia.com, Retrieved 2026]. |
What compounding looks like centers on data and care continuity. Each patient interaction across different specialties within Tia's integrated system enriches a unified health profile. This longitudinal dataset can improve care personalization and population health management, a capability Tia explicitly plans to measure through outcomes like reduced cardiovascular events [MedCity News, Retrieved 2026]. Furthermore, a positive care experience in one life stage (e.g., gynecology) naturally funnels patients into adjacent services (e.g., fertility, then menopause management) within the same ecosystem, improving lifetime value and reducing customer acquisition costs. The reported 80%+ retention suggests this flywheel for deepening patient relationships is already in motion [Fierce Healthcare, Retrieved 2026].
The size of the win can be framed by looking at a scaled, publicly traded peer in a related space. Maven Clinic, a virtual-first platform focused on family and women's health, achieved a valuation reported at over $1 billion [Forbes, 2021]. If Tia successfully executes on its hybrid clinic-and-virtual model and expands its health system partnerships, it could plausibly target a similar or greater valuation by capturing a more comprehensive care continuum. This represents a scenario where Tia becomes a category-defining platform, not just a clinic chain. (scenario, not a forecast).
Data Accuracy: YELLOW -- Traction metrics are self-reported via media. Growth scenario plausibility is supported by announced partnerships and product roadmaps.
Sources
PUBLIC
[Fierce Healthcare, Oct 2022] Tia clinches $100M to build out clinics, virtual care as investors bank on women's health startups | https://www.fiercehealthcare.com/tech/tia-clinches-100m-as-investors-bank-women-s-health-star
[Fortune, May 2022] Women's health clinic Tia launches fertility services with spotlight on mental health | https://fortune.com/2022/05/19/exclusive-womens-health-clinic-tia-launches-fertility-services-with-a-spotlight-on-mental-health/
[The Helm] Tia co-founder Carolyn Witte opens up about how she built the fastest growing modern medical home for women across the country. | https://thehelm.co/tia-carolyn-witte-interview/
[TechCrunch, Mar 2019] Tia launches a clinic that places the menstrual cycle at the center of care | https://techcrunch.com/2019/03/06/tia-launches-a-clinic-that-places-the-menstrual-cycle-at-the-center-of-care/
[Oprah Daily] Healthcare company Tia streamlining women’s medicine | https://www.oprahdaily.com/life/work-money/a44533955/healthcare-company-tia-streamlining-womens-medicine/
[Business Insider, Oct 2025] Tia CEO Felicity Yost on workforce reductions | https://www.businessinsider.com/womens-health-startup-tia-cut-23-of-workforce-layoff-2025-10
[Forbes, Nov 2018] 30 Under 30 2019: Consumer Technology | https://www.forbes.com/pictures/5be58347a7ea437059168d58/felicity-yost-28-and-caro/
[asktia.com] Tia: The Modern Medical Home for Women | https://asktia.com
[MobiHealthNews] Women's healthcare startup Tia secures $100M for company growth | https://www.mobihealthnews.com/news/womens-healthcare-startup-tia-secures-100m-company-growth
[AHA, Oct 2023] Women’s health startup Tia makes an impact treating ‘medical orphans’ | https://www.aha.org/aha-center-health-innovation-market-scan/2023-10-24-womens-health-startup-tia-makes-impact-treating-medical-orphans
[Businesswire, May 2022] Tia and UCSF Health Announce Partnership to Transform Women's Healthcare | https://www.businesswire.com/news/home/20220519005150/en/Tia-and-UCSF-Health-Announce-Partnership-to-Transform-Women%E2%80%99s-Healthcare
[Fierce Healthcare] Tia leadership transition | https://www.fiercehealthcare.com/tech/tia-clinches-100m-as-investors-bank-women-s-health-star
[asktia.com, Retrieved 2026] Tia Services | https://asktia.com
[MedCity News, Retrieved 2026] Tia Health to measure outcomes, partners with Talkspace | https://medcitynews.com
[Businesswire, Retrieved 2026] Tia launches Hormone & Vitality Assessment | https://www.businesswire.com
[HCI Innovation Group, Retrieved 2026] Tia and UCSF Health partnership details | https://www.hciinnovationgroup.com
[Crunchbase] Crunchbase Company Profiles for Maven Clinic, Ovia Health, Bia Care | https://www.crunchbase.com
[Grand View Research] Women's Health Market Size Report, 2023-2030 | https://www.grandviewresearch.com/industry-analysis/womens-health-market
[Precedence Research] Women's Digital Health Market Size, 2023-2032 | https://www.precedenceresearch.com/women-digital-health-market
Articles about Tia
- Tia's Nine Clinics and 100,000 Services Land a $132 Million Bet on Integrated Women's Health — The hybrid provider, now led by Felicity Yost, is building a network of 'medical homes' to treat conditions from PCOS to perimenopause, backed by partners like UCSF Health.